Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk M Hermann

Showing results (171-180 of 363) with videos related to

Pageof 37
Sort By:
Plos One|March 12, 2014
Physical, cognitive and emotional factors contributing to quality of life, functional health and participation in community dwelling in chronic kidney diseaseUlla K Seidel, Janine Gronewold, Michaela Volsek, et al.
Stroke|December 31, 2004
Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthaseErtugrul Kilic, Ulkan Kilic, Christian M Matter, et al.
Plos One|November 12, 2016
Cognitive Performance Is Highly Stable over a 2-Year-Follow-Up in Chronic Kidney Disease Patients in a Dedicated Medical EnvironmentJanine Gronewold, Olga Todica, Ulla K Seidel, et al.
Frontiers in Medicine|March 6, 2023
Developing a novel tool to assess the ability to self-administer medication - A systematic evaluation of patients' video recordings in the ABLYMED studyAnneke Luegering, Robert Langner, Stefan Wilm, et al.
Aging and Disease|December 16, 2025
Vascular Aging and Multi-Omic Regulation in Ischemic Stroke: Toward Precision NeurorepairDenisa Floriana Pirscoveanu, Dirk M Hermann, Mihaela Abuzan, et al.
Neurobiology of Disease|August 29, 2015
Sustained neurological recovery induced by resveratrol is associated with angioneurogenesis rather than neuroprotection after focal cerebral ischemiaDirk M Hermann, Anil Zechariah, Britta Kaltwasser, et al.
Neural Plasticity|December 10, 2019
Intracortical Administration of the Complement C3 Receptor Antagonist Trifluoroacetate Modulates Microglia Reaction after Brain InjuryRoxana Surugiu, Bogdan Catalin, Danut Dumbrava, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 30, 2015
The indirect NMDAR antagonist acamprosate induces postischemic neurologic recovery associated with sustained neuroprotection and neuroregenerationThorsten R Doeppner, Jens R Pehlke, Britta Kaltwasser, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 30, 2016
Lithium-induced neuroprotection in stroke involves increased miR-124 expression, reduced RE1-silencing transcription factor abundance and decreased protein deubiquitination by GSK3β inhibition-independent pathwaysThorsten R Doeppner, Britta Kaltwasser, Eduardo H Sanchez-Mendoza, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 16, 2026
Chronobiological disruption in ADHD: Developmental mechanisms linking sleep, behavior, and comorbid conditionsDaniela Glavan, Ion Udristoiu, Dirk M Hermann, et al.
Pageof 37

Showing results (171-180 of 363) with videos related to

Sort By:
Pageof 37
Plos One|March 12, 2014
Physical, cognitive and emotional factors contributing to quality of life, functional health and participation in community dwelling in chronic kidney diseaseUlla K Seidel, Janine Gronewold, Michaela Volsek, et al.
Stroke|December 31, 2004
Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthaseErtugrul Kilic, Ulkan Kilic, Christian M Matter, et al.
Plos One|November 12, 2016
Cognitive Performance Is Highly Stable over a 2-Year-Follow-Up in Chronic Kidney Disease Patients in a Dedicated Medical EnvironmentJanine Gronewold, Olga Todica, Ulla K Seidel, et al.
Frontiers in Medicine|March 6, 2023
Developing a novel tool to assess the ability to self-administer medication - A systematic evaluation of patients' video recordings in the ABLYMED studyAnneke Luegering, Robert Langner, Stefan Wilm, et al.
Aging and Disease|December 16, 2025
Vascular Aging and Multi-Omic Regulation in Ischemic Stroke: Toward Precision NeurorepairDenisa Floriana Pirscoveanu, Dirk M Hermann, Mihaela Abuzan, et al.
Neurobiology of Disease|August 29, 2015
Sustained neurological recovery induced by resveratrol is associated with angioneurogenesis rather than neuroprotection after focal cerebral ischemiaDirk M Hermann, Anil Zechariah, Britta Kaltwasser, et al.
Neural Plasticity|December 10, 2019
Intracortical Administration of the Complement C3 Receptor Antagonist Trifluoroacetate Modulates Microglia Reaction after Brain InjuryRoxana Surugiu, Bogdan Catalin, Danut Dumbrava, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 30, 2015
The indirect NMDAR antagonist acamprosate induces postischemic neurologic recovery associated with sustained neuroprotection and neuroregenerationThorsten R Doeppner, Jens R Pehlke, Britta Kaltwasser, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 30, 2016
Lithium-induced neuroprotection in stroke involves increased miR-124 expression, reduced RE1-silencing transcription factor abundance and decreased protein deubiquitination by GSK3β inhibition-independent pathwaysThorsten R Doeppner, Britta Kaltwasser, Eduardo H Sanchez-Mendoza, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 16, 2026
Chronobiological disruption in ADHD: Developmental mechanisms linking sleep, behavior, and comorbid conditionsDaniela Glavan, Ion Udristoiu, Dirk M Hermann, et al.
Pageof 37